- Home
- ELMD vs HELP Comparison
ELMD vs HELP Comparison
Compare ELMD & HELP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ELMD | HELP |
|---|---|---|
| Founded | 1992 | N/A |
| Country | United States | Canada |
| Employees | N/A | 50 |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 208.1M | 214.5M |
| IPO Year | 2010 | N/A |
Fundamental Metrics
Financial Performance| Metric | ELMD | HELP |
|---|---|---|
| Price | $38.08 | $4.60 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 2 |
| Target Price | $36.00 | ★ $51.50 |
| AVG Volume (30 Days) | 48.4K | ★ 567.3K |
| Earning Date | 05-12-2026 | 07-01-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 46.55 | N/A |
| EPS | ★ 0.91 | N/A |
| Revenue | ★ $54,716,000.00 | N/A |
| Revenue This Year | $15.59 | N/A |
| Revenue Next Year | $11.51 | N/A |
| P/E Ratio | $40.92 | ★ N/A |
| Revenue Growth | ★ 13.83 | N/A |
| 52 Week Low | $17.73 | $3.76 |
| 52 Week High | $40.00 | $8.55 |
Technical Indicators
Market Signals| Indicator | ELMD | HELP |
|---|---|---|
| Relative Strength Index (RSI) | 61.62 | 52.71 |
| Support Level | $23.47 | $4.32 |
| Resistance Level | $40.00 | $4.75 |
| Average True Range (ATR) | 1.98 | 0.30 |
| MACD | -0.38 | 0.07 |
| Stochastic Oscillator | 64.75 | 85.00 |
Price Performance
Historical ComparisonAbout ELMD Electromed Inc.
Electromed Inc is a United States-based company that develops, manufactures, markets, and sells products that provide airway clearance therapy, including the SmartVest Airway Clearance System and related products, to patients with compromised pulmonary function with a commitment to excellence and compassionate service. The SmartVest System features a programmable air pulse generator, a therapy garment worn over the upper body and a connecting hose, which together provide safe, comfortable, and effective airway clearance therapy.
About HELP Cybin Inc. Common Stock
Helus Pharma Inc, the commercial operating name of Cybin Inc, is a clinical-stage pharmaceutical company focused on developing proprietary neuroactive compounds, referred to as NSAs, which are synthetic molecules designed to target serotonin pathways. The company's programs are aimed at treating mental health conditions such as depression and anxiety. Its pipeline includes HLP003, which is in clinical development for the adjunctive treatment of depressive disorder, and HLP004, which is in clinical development for generalized anxiety disorder. The company also conducts research on additional investigational compounds.